valyl-prolyl-glycyl-valyl-glycine: a synthetic elastin peptide; do not confuse with polymeric VPGVG [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6452594 |
| SCHEMBL ID | 1371152 |
| MeSH ID | M0249925 |
| Synonym |
|---|
| vpgvg |
| val-pro-gly-val-gly |
| glycine, n-(n-(n-(1-l-valyl-l-prolyl)glycyl)-l-valyl)- |
| valyl-prolyl-glycyl-valyl-glycine |
| 52231-42-2 |
| n-(n-(n-(1-l-valyl-l-prolyl)glycyl)-l-valyl)glycine |
| SCHEMBL1371152 |
| DTXSID90200279 |
| val-pro-gly-val-gly-oh |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.54) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||